Journal of Experimental Pharmacology · 2021 · 11 citations · 17 references
PharmacyInfectious DiseasesMedicinal ChemistryDrug DiscoveryMolecular VirologyVirologyAntiviral AgentsAntiviral PharmacologyAntiviral PharmacotherapyAntiviral TherapyAntiviral Natural ProductsAntiviral Safety AssessmentAntiviral TherapeuticsCytopathic EffectsIn Vivo Efficacy TestingIn Vivo StudiesInfluenza Antiviral TherapyViral Cytopathic Effect
Background: Recent viral pandemics have challenged the global scientific community to immediately develop new therapies. The fastest approach to develop these is to explore natural products for their efficacies and repurposing of already approved molecules. Keeping global emergency in view, researchers at Shreepad Shree Vallabh SSV Phytopharmaceuticals developed the Curvic TM (SSV-003) formulation, comprising of curcumin, vitamin C, vitamin K2-7, selenomethionine and Zinc. Methods: Researchers have systematically studied the SSV-003 formulation for its in vitro efficacy against influenza A virus (H1N1) (ATCC ® VR-219™) and human beta coronavirus (ATCC ® VR1558™) using MDCK & HCT-8 cell lines, respectively, in vivo efficacy studies of SSV-003 on influenza A virus infected Balb/c mice, and acute toxicity studies as per OECD guidelines. Results: Formulation SSV-003 showed potent antiviral activities against both the selected virus strains. Its IC 50 was significantly lessthan ribavirin against influenza A-H1N1-VR219, with no cytopathic effect. SSV-003 showed IC 50 of 2.26 μg/mL against human beta coronavirus, which was near to the IC 50 of ribavirin (2.25 μg/mL) and was less than remedisivir (6.23 μg/mL) with no cytopathic effect. In-vivo studies in an influenza A virus infected mice model showed a significantly higher TCID50 value in the infected control group as compared to test groups. Animals treated with SSV-003 showed a dose dependent decrease in TCID50. Formulation SSV-003 at the dose of 500, 1,000, and 1,500 mg/kg body weight showed 85.9%, 94.6%, and 95.1% decreases in infection as compared to the infected control group. Dose-dependent significant increases in CD4+, CD8+ counts, IgG and IgM levels were observed in SSV-003 treated groups as compared to the infected control group and remedisivir treated group. In the acute oral toxicity study, no mortality or morbidity was observed. Conclusion: The data from these preclinical studies provide strong evidence of potent and safe antiviral and immunomodulatory activity of SSV-003. Keywords: curcumin, antiviral, coronavirus, vitamin C
17
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang, Yeming Wang, Xingwang Li et al. · The Lancet · 2020 · 51.8K citations · Full text
Inhibition of Enveloped Viruses Infectivity by Curcumin
Tzu-Yen Chen, Da‐Yuan Chen, Hsiao‐Wei Wen et al. · PLoS ONE · 2013 · 177 citations · Full text